Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle

Journal of Immunology

Volumn 174, Issue 11, 2005, Pages 7285-7291

  Abonia, J Pablo ^a,f   Friend, Daniel S ^a   Austen Jr , William G ^b   Moore Jr , Francis D ^a   Carroll, Michael C ^c   Chan, Rodney ^a   Afnan, Jalil ^a   Humbles, Alison ^d   Gerard, Craig ^d   Knight, Pamela ^e   Kanaoka, Yoshihide ^a   Yasuda, Shinsuke ^a   Morokawa, Nasa ^a   Austen, K Frank ^a   Stevens, Richard L ^a   Gurish, Michael F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN M; LEUKOTRIENE C4 SYNTHASE; MAST CELL PROTEASE 5; N DEACETYLASE; N SULFOTRANSFERASE 2; PROSTAGLANDIN SYNTHASE; SERINE PROTEINASE; STEM CELL FACTOR; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MAST CELL DEGRANULATION; MOUSE; MUSCLE INJURY; MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPERFUSION INJURY; SKELETAL MUSCLE; TRANSGENIC MOUSE;

EID: 21044433149     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.11.7285     Document Type: Article

References (46)

1. Weiser, M. R., J. P. Williams, F. D. Moore, Jr., L. Kobzik, M. Ma, H. B. Hechtman, and M. C. Carroll. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183: 2343-2348.
2. Kyriakides, C., W. Austen, Jr., Y. Wang, J. Favuzza, L. Kobzik, F. D. Moore, Jr., and H. B. Hechtman. 1999. Skeletal muscle reperfusion injury is mediated by neutrophils and the complement membrane attack complex. Am. J. Physiol. 277: C1263-C1268.
3. Lazarus, B., A. Messina, J. E. Barker, J. V. Hurley, R. Romeo, W. A. Morrison, and K. R. Knight. 2000. The role of mast cells in ischaemia- reperfusion injury in murine skeletal muscle. J. Pathol. 191: 443-448.
4. Mukundan, C., M. F. Gurish, K. F. Austen, H. B. Hechtman, and D. S. Friend. 2001. Mast cell mediation of muscle and pulmonary injury following hindlimb ischemia-reperfusion. J. Histochem. Cytochem. 49: 1055-1056.
5. Bortolotto, S. K., W. A. Morrison, X. Han, and A. Messina. 2004. Mast cells play a pivotal role in ischaemia reperfusion injury to skeletal muscles. Lab. Invest. 84: 1103-1111.
6. Katz, H. R., M. B. Raizman, C. S. Gartner, H. C. Scott, A. C. Benson, and K. F. Austen. 1992. Secretory granule mediator release and generation of oxidative metabolites of arachidonic acid via Fc-IgG receptor bridging in mouse mast cells. J. Immunol. 148: 868-871.
7. 2. J. Immunol. 139: 3431-3441.
8. Plaut, M., J. H. Pierce, C. J. Watson, J. Hanley-Hyde, R. P. Nordan, and W. E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature 339: 64-67.
9. Burd, P. R., H. W. Rogers, J. R. Gordon, C. A. Martin, S. Jayaraman, S. D. Wilson, A. M. Dvorak, S. J. Galli, and M. E. Dorf. 1989. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170: 245-257.
10. Miyajima, I., D. Dombrowicz, T. R. Martin, J. V. Ravetch, J. P. Kinet, and S. J. Galli. 1997. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII: assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99: 901-914.
11. Dombrowicz, D., V. Flamand, I. Miyajima, J. V. Ravetch, S. J. Galli, and J. P. Kinet. 1997. Absence of FcεRIα chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis: evidence of competition between FcεRI and FcγRIII for limiting amounts of FcRβ and γ chains. J. Clin. Invest. 99: 915-925.
12. Lim, H. W., D. He, S. Esquenazi-Behar, K. B. Yancey, and N. A. Soter. 1991. C5a, cutaneous mast cells, and inflammation: in-vitro and in vivo studies in a murine model. J. Invest. Dermatol. 97: 305-311.
13. Johnson, A. R., T. E. Hugli, and H. J. Muller-Eberhard. 1975. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28: 1067.
14. el Lati, S. G., C. A. Dahinden, and M. K. Church. 1994. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J. Invest. Dermatol. 102: 803-806.
15. Cerniway, R. J., Z. Yang, M. A. Jacobson, J. Linden, and G. P. Matherne. 2001. Targeted deletion of A3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am. J. Physiol. 281:H1751-H1758.
16. Zhong, H., S. G. Shlykov, J. G. Molina, B. M. Sanborn, M. A. Jacobson, S. L. Tilley, and M. R. Blackburn. 2003. Activation of murine lung mast cells by the adenosine A3 receptor. J. Immunol. 171: 338-345.
17. Russell, E. S. 1979. Hereditary anemias of the mouse: a review for geneticists. Adv. Genet. 20: 357-459.
18. v mice and their increase by bone marrow transplantation. Blood 52: 447.
19. Bernstein, A., B. Chabot, P. Dubreuil, A. Reith, K. Nocka, S. Majumder, P. Ray, and P. Besmer. 1990. The mouse W/c-kit locus. Ciba Found. Symp. 148: 158-166.
20. Humphries, D. E., G. W. Wong, D. S. Friend, M. F. Gurish, W. T. Qiu, C. Huang, A. H. Sharpe, and R. L. Stevens. 1999. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 400: 769-772.
21. Hopken, U. E., B. Lu, N. P. Gerard, and C. Gerard. 1996. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature 383: 86-89.
22. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157: 549-556.
23. 4 synthase. J. Biol. Chem. 276: 22608-22613.
24. Knighi, P. A., S. H. Wright, C. E. Lawrence, Y. Y. Paterson, and H. R. Miller. 2000. Delayed expulsion of the nematode Trichinella spiralis in mice lacking the mucosal mast cell-specific granule chymase, mouse mast cell protease-1. J. Exp. Med. 192: 1849-1856.
25. Humbles, A. A., B. Lu, C. A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406: 998-1001.
26. McNeil, H. P., K. F. Austen, L. L. Somerville, M. F. Gurish, and R. L. Stevens. 1991. Molecular cloning of the mouse mast cell protease 5 gene: a novel secretory granule protease expressed early in the differentiation of serosal mast cells. J. Biol. Chem. 266: 20316-20333.
27. Stevens, R. L., D. Qui, H. P. McNeil, D. S. Friend, J. E. Hunt, K. F. Austen, and J. Zhang. 1996. Transgenic mice that possess a disrupted mast cell protease 5 gene cannot store carboxypeptidase A in their granules. FASEB J. 10: 1307.
28. Ervasti, J. M. 2003. Costameres: the Achilles' heel of Herculean muscle. J. Biol. Chem. 278: 13591-13594.
29. McNeil, H. P., D. P. Frenkel, K. F. Austen, D. S. Friend, and R. L. Stevens. 1992. Translation and granule localization of mouse mast cell protease 5: immunodetection with specific antipeptide Ig. J. Immunol. 149: 2466-2472.
30. de Vries, B., J. Kohl, W. K. Leclercq, T. G. Wolfs, A. A. van Bijnen, P. Heeringa, and W. A. Buurman. 2003. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils. J. Immunol. 170: 3883-3889.
31. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized TNF-α/cachectin by mouse mast cells stimulated via FcεRI: a mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174: 103-107.
32. Kolaczkowska, E., S. Shahzidi, R. Seljelid, N. van Rooijen, and B. Plytycz. 2002. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation 26: 61-71.
33. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129: 1627-1631.
34. Stevens R. L., G. W. Wong, and D. E. Humphries. 2000. Serglycin proteoglycans: the family of proteoglycans stored in the secretory granules of certain effector cells of the immune system. In Proteoglycans: Structure, Biology, and Molecular Interactions. R. V. Iozzo, ed. Dekker, New York, p. 177-199.
35. Eriksson, I., D. Sandback, B. Ek, U. Lindahl, and L. Kjellén. 1994. cDNA cloning and sequencing of mouse mastocytoma glucosaminyl N-deacetylase/N-sulfotransferase, an enzyme involved in the biosynthesis of heparin. J. Biol. Chem. 269: 10438-10443.
36. Lundequist, A., E. Tchougounova, M. Abrink, and G. Pejler. 2004. Cooperation between mast cell carboxypeptidase A and the chymase mouse mast cell protease 4 in the formation and degradation of angiotensin II. J. Biol. Chem. 279: 32339-32344.
37. Forsberg, E., G. Pejler, M. Ringvall, C. Lunderius, B. Tomasini-Johansson, M. Kusche-Gullberg, I. Eriksson, J. Ledin, L. Hellman, and L. Kjellen. 1999. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400: 773-776.
38. Wong, G. W., Y. Tang, E. Feyfant, A. Sali, L. Li, Y. Li, C. Huang, D. S. Friend, S. A. Krilis, and R. L. Stevens. 1999. Identification of a new member of the tryptase family of mouse and human mast cell proteases that possesses a novel C-terminal hydrophobic extension. J. Biol. Chem. 274: 30784-30793.
39. Hunt, J. E., R. L. Stevens, K. F. Austen, J. Zhang, Z. Xia, and N. Ghildyal. 1996. Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse. J. Biol. Chem. 271: 2851-2855.
40. Reynolds, D. S., R. L. Stevens, W. S. Lane, M. H. Carr, K. F. Austen, and W. E. Serafin. 1990. Different mouse mast cell populations express various combinations of at least six distinct mast cell serine proteases. Proc. Natl. Acad. Sci. USA 87: 3230-3234.
41. 7 integrin) for tissue-specific homing. J. Exp. Med. 194: 1243-1252.
42. Sonoda, T., C. Hayashi, Y. Kitamura, T. Nakano, M. Bessho, K. Hirashima, E. Miyazaki, and H. Kara. 1984. Poor response of Wv/Wx mice to a grafted neutrophilia-inducing, colony-stimulating-factor-producing tumor. Exp. Hematol. 12: 850-855.
43. Cynshi, O., K. Satoh, Y. Shimonaka, K. Hattori, H. Nomura, N. Imai, and K. Hirashima. 1991. Reduced response to granulocyte colony-stimulating factor in W/Wv and Sl/Sld mice. Leukemia 5: 75-77.
44. Huang, C., D. S. Friend, W. T. Qiu, G. W. Wong, G. Morales, J. Hunt, and R. L. Stevens. 1998. Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J. Immunol. 160: 1910-1919.
45. Le Trong, H., H. Neurath, and R. G. Woodbury. 1987. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells. Proc. Natl. Acad. Sci. USA 84: 364-367.
46. Henningsson, F., J. Ledin, C. Lunderius, M. Wilen, L. Hellman, and G. Pejler. 2002. Altered storage of proteases in mast cells from mice lacking heparin: a possible role for heparin in carboxypeptidase A processing. Biol. Chem. 383: 793-801.